Antibody–drug conjugates amplify cancer immunotherapy in selected solid tumors
A review of clinical and preclinical evidence finds that antibody–drug conjugates can improve outcomes with immune checkpoint inhibitors in several ...
A review of clinical and preclinical evidence finds that antibody–drug conjugates can improve outcomes with immune checkpoint inhibitors in several ...
A 2026 mini review finds that CT is established for anatomical assessment and surgical planning after neoadjuvant immunotherapy in resectable ...
A prespecified interim analysis of the phase 3 HARMONi-2 trial shows ivonescimab achieved median overall survival of 30.8 months versus ...
In a 20-patient retrospective study, higher cerebrospinal fluid almonertinib exposure was associated with better brain-MRI response, while no significant exposure-response ...
In the phase 3 REZILIENT 3 trial, adding zipalertinib to platinum-pemetrexed chemotherapy extended median progression-free survival from 8.5 to 14.5 ...
A case report and literature review describe acute myeloid leukemia developing 32 months into icotinib therapy for EGFR-mutated lung cancer, ...
University of Michigan researchers report that the molecular glue RPT04402 stabilizes the trimeric tumor suppressor PP2A, shrinking KRAS-mutant lung tumors ...
A single-center cohort study linked checkpoint inhibitor-containing therapy with longer unadjusted progression-free survival in advanced SMARCA4-deficient thoracic tumors, but adjusted ...
A Hong Kong prospective cohort study of 327 newly diagnosed non-small cell lung cancer patients found that objective cancer-related cognitive ...
Preclinical experiments found that tetrandrine promoted ferroptosis in NSCLC models, enhanced CD8⁺ T-cell effector responses and improved anti-PD-1 tumor suppression ...
A clinical sequencing study associated tumor mutation burden, whole-genome doubling and mutations in four genes with worse survival in early-stage ...
A retrospective study of 154 patients links adjuvant EGFR inhibitors with longer three-year disease-free survival after surgery for non-small cell ...
A study in non-small cell lung cancer models found that FBXO28 promotes proliferation, migration and invasion by ubiquitinating BRD4 and ...
A network-pharmacology and cell-based study identified 95 candidate targets for Pei Yuan Yi Fei decoction in non-small cell lung cancer, ...
A mouse study found that directly reducing lung cancer cells’ dependence on phospholipase D1 significantly slowed tumor growth, but clinical ...
A prospective single-center cohort linked baseline thyroid autoantibodies and higher TSH to more immune-related thyroid dysfunction during advanced lung cancer ...
A Nepal single-centre retrospective study characterized 51 ALK- or ROS1-positive cases, including 49 non-small cell lung cancers and two inflammatory ...
A nine-patient phase I trial found that TIGIT-disrupted NK510 could be combined with PD-1 blockade without observed dose-limiting toxicities in ...
A retrospective study of 165 surgically treated patients found that machine-learning analysis of whole-slide images linked CD8-positive immune-cell density, Foxp3-positive ...
A new review argues that epigenetic plasticity in drug-tolerant persister cells, not fixed cancer stem cell identity, may explain relapse ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.